Publications by authors named "Giulia Palazzo"

Claim this Profile
C
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. 2025, , 595.
Nicola Sgherza, Olga Battisti, Paola Curci, Concetta Conticello, Salvatore Palmieri, Giulia Palazzo

Pharmaceuticals (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.
Nicola Sgherza, Olga Battisti, Paola Curci, Concetta Conticello, Salvatore Palmieri, Giulia Palazzo

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Giuseppe Mele, Daniele Derudas, Concetta Conticello, Gregorio Barilà, Massimo Gentile, Giulia Palazzo

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.
Vanda Strafella, Immacolata Attolico, Paola Carluccio, Francesco Tarantini, Paola Curci, Giulia Palazzo

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Giuseppe Mele, Nicola Di Renzo, Nicola Cascavilla, Angelo Michele Carella, Attilio Guarini, Giulia Palazzo

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral antivirals against Sars-CoV-2 in multiple myeloma outpatients: a case series.
Giuseppe Bruno, Serena Perelli, Giulia Palazzo, Giuseppina De Vita, Giovanni Battista Buccoliero

Recenti Prog Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, Fabio Giglio, Mario Arpinati, Giulia Palazzo

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
Salvatore Leotta, Uros Markovic, Maria Cristina Pirosa, Stefania Stella, Stefania Tringali, Giulia Palazzo

Ann Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).
Anna Mele, Eleonora Prete, Clara De Risi, Stefania Citiso, Giuseppina Greco, Giulia Palazzo

Ann Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of early relapsed plasma cells leukemia after unrelated bone marrow transplant with KRD (carfilzomib, lenalidomide and dexamethasone): a case report.].
Giulia Palazzo

Recenti Prog Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.
Giuseppe Mele, Domenico Pastore, Nicola Di Renzo, Alberto Fragasso, Attilio Guarini, Giulia Palazzo

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients.
Francesco Gaudio, Patrizio Mazza, Anna Mele, Giulia Palazzo, Angelo Michele Carella

Ann Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP).
Francesco Gaudio, Patrizio Mazza, Angelo Michele Carella, Anna Mele, Giulia Palazzo

Clin Lymphoma Myeloma Leuk· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
Vincenzo Pavone, Anna Mele, Daniela Carlino, Giorgina Specchia, Francesco Gaudio, Giulia Palazzo

Ann Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.
Raffaella Rossio, Barbara Ferrari, Andrea Cairo, Ilaria Mancini, Giovanni Pisapia, Giulia Palazzo

Blood Transfus· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis